PREGNANCY
THROMBOPROPHYLAXIS
| Inherited thrombophilia without previous VTE |
Br J Haematol. 2001 May;113(2):553-5.
The risk of pregnancy-related venous thromboembolism in women who are homozygous for factor V Leiden.
Middeldorp S, Libourel EJ, Hamulyak K, Van der Meer J, Buller HR.
Department of Vascular Medicine, Academic Medical Centre, Amsterdam, The Netherlands. S. Middeldorp@amc.uva.nl
The risk of venous thromboembolism (VTE) is increased in pregnancy and during the post-partum period. The absolute risk for pregnancy-related VTE in heterozygous women with the factor V Leiden mutation is approximately 2%, but studies on this risk for homozygous women show conflicting results. In a retrospective family study, we found that the risk of pregnancy-related VTE in women with a symptomatic first-degree relative was 17% per pregnancy (95%CI 4.7-37.4). Anticoagulant prophylaxis during the post-partum period appears to be indicated in asymptomatic homozygous women from symptomatic kindred, whereas this could be decided on an individual basis during pregnancy.
Thank you for choosing to visit us.
This is the personal website of David A Viniker MD FRCOG, Consultant Obstetrician and Gynaecologist at Whipps Cross University Hospital, London - Specialist Interests - Reproductive Medicine including Infertility, PCOS, PMS, Menopause and HRT.
I do hope that you find the answers to your women's health questions in the patient information and medical advice provided. If you still have unanswered questions, please consider entering them into one of our forums and I will try to assist you.
